Last reviewed · How we verify
NCT06256042
Effectiveness of Arthrocentesis and the Occlusal Splint in Treatment of the TMJ
NA trial testing Occlusal splint in Temporomandibular Joint Disc Displacement in 24 participants. Completed in 15 January 2024.
28 February 2022
Quick facts
| Lead sponsor | University of Sao Paulo General Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 24 |
| Start date | 30 May 2021 |
| Primary completion | 28 February 2022 |
| Estimated completion | 15 January 2024 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Occlusal splint
- Arthrocentesis
Conditions studied
- Temporomandibular Joint Disc Displacement — all drugs for Temporomandibular Joint Disc Displacement →
- Anterior Disc Displacement — all drugs for Anterior Disc Displacement →
Sponsor
University of Sao Paulo General Hospital
Who can join
Adults 18 to 60, any sex, with Temporomandibular Joint Disc Displacement or Anterior Disc Displacement. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to compare occlusal splint and arthrocentesis in patients with disc displacement with/without reduction. The main question it aims to answer are: • Is there a more effective treatment for this cases? Participants will answer a questionary about pain and functional limitations. Researchers will compare Group 1(occlusal plate) and Gruoup 2 (arthrocentesis) to see if there is pain reduction and functional improvement in patients with disc displacement with/without reduction
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06256042
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Occlusal splint
Trials testing the same drug.
- NCT07082972 — EMG-Based Evaluation of Occlusal Splint and Masseter Botox Effects on Head and Neck Muscles · Phase 4 · recruiting
- NCT07095101 — ePROPP - eHealth for Preventing and Reducing Orofacial Pain in the Population · NA · not yet recruiting
- NCT06593821 — Effect of Different Treatment Techniques on Masseter Muscle Thickness · NA · completed
- NCT04934449 — Occlusal Splints in the Treatment of Sleep Bruxism · NA · completed
- NCT03456154 — Botox vs Occlusal Splint for Masseter Pain · Phase 4 · completed
Other University of Sao Paulo General Hospital trials
Trials by the same sponsor.
- NCT07275580 — Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases · Phase 4 · not yet recruiting
- NCT07478094 — Longitudinal Outcomes of Patients With Group 3 Pulmonary Hypertension Treated With Iloprost · not yet recruiting
- NCT07341386 — Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases · Phase 4 · not yet recruiting
- NCT07242092 — Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs · Phase 4 · not yet recruiting
- NCT07484152 — Motor and Non-Motor Effects of Low-Intensity Focused Ultrasound (LIFU) as a Neuromodulation Tool in Essential Tremor · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06256042 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Sao Paulo General Hospital
- Last refreshed: 13 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06256042.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing